Stocks TradingCharts.com

stocks prices, charts & quotes

Free Stock Prices, Charts & Stock Price Quotes

Search
Symbol Search Browse Symbols My Charts Menu
QUICK QUOTE
QUICK CHART
F.A.Questions Suggestion Box Advertising Info Commodity Charts Forex Markets

Stocks & Financial News

Breaking financial news 24/7 courtesy of TradingCharts.com Inc. / TFC Commodity Charts

Ascent Industries Reports First Quarter 2024 Results

OAK BROOK, Ill., May 8, 2024 (BUSINESS WIRE) --
Ascent Industries Co. (Nasdaq: ACNT) ("Ascent" or the "Company"), an industrials company focused on the production of specialty chemicals and industrial tubular products, is reporting its results for the first quarter ended March 31, 2024.

First Quarter 2024 Summary(1)
------------------------------------------------------------------------------------------------------
                             
------------------------------------------ -------------------- -------------------- --------------------
(in millions, except per share and margin)        Q1 2024              Q1 2023              Change
------------------------------------------ -------------------- -------------------- --------------------
Net Sales                                          $44.1                $54.9               (19.6)%
------------------------------------------ -------------------- -------------------- --------------------
Gross Profit                                       $2.5                 $1.5                 72.4%
------------------------------------------ -------------------- -------------------- --------------------
Gross Profit Margin                                5.7%                 2.7%                300bps
------------------------------------------ -------------------- -------------------- --------------------
Net (Loss)                                        $(4.7)               $(5.8)                18.6%
------------------------------------------ -------------------- -------------------- --------------------
Diluted (Loss) per Share                          $(0.47)              $(0.57)               17.5%
------------------------------------------ -------------------- -------------------- --------------------
Adjusted EBITDA                                   $(3.1)               $(3.7)                16.6%
------------------------------------------ -------------------- -------------------- --------------------
Adjusted EBITDA Margin                            (7.1)%               (6.8)%               (30)bps
------------------------------------------ -------------------- -------------------- --------------------
____________________________

Management Commentary

"The first quarter of 2024 marked a period of structural cost reduction and stabilization efforts across the enterprise," said Ascent CEO Bryan Kitchen. "Without question, our initial efforts to optimize both cash and costs have helped drive year-over-year improvements across our consolidated gross margin and bottom line, while operating within the confines of our own free cash flow. Aggressive self-help has been at the core of our ability to overcome ongoing market headwinds that have resulted in a year-over-year decline in total net sales.

"As promised, in just a short period of time we have made progress in laying the groundwork for driving profitable growth through the optimization of our product mix while recapitalizing our SG&A across both segments. These actions, coupled with a continued focus on driving efficiencies across all sites and functions, will create a more predictable, reliable, and profitable operating model moving forward. Momentum is building, and we expect continued improvements in our financial results throughout 2024. We believe we are on the right track to create durable value for shareholders."

First Quarter 2024 Financial Results

Net sales from continuing operations were $44.1 million compared to $54.9 million in the first quarter of 2023, primarily attributable to decreased end-market demand and de-stocking trends across both segments.

Gross profit from continuing operations improved to $2.5 million, or 5.7% of net sales, compared to $1.5 million, or 2.7% of net sales, in the first quarter of 2023. The increase was primarily attributable to improved strategic sourcing initiatives and cost improvements.

Net loss from continuing operations decreased to $4.7 million, or $(0.47) diluted loss per share, compared to net loss from continuing operations of $5.8 million, or $(0.57) diluted earnings per share, in the first quarter of 2023. The decrease was primarily attributable to the aforementioned increases in gross profit and a year-over-year decrease in interest expense due to lower debt outstanding.

Adjusted EBITDA improved to $(3.1) million compared to $(3.7) million in the first quarter of 2023, primarily driven by the aforementioned cost optimization efforts. Adjusted EBITDA margin was (7.1)% compared to (6.8)% in the prior year period, with the decline primarily a result of the aforementioned lower net sales base.

Segment Results

Ascent Chemicals - net sales in the first quarter of 2024 were $20.3 million compared to $23.7 million in the first quarter of 2023. Operating loss in the first quarter was $1.4 million compared to operating income of $1.4 million in the prior year period. Adjusted EBITDA in the first quarter was $(0.3) million compared to $2.5 million in the prior year period. As a percentage of segment net sales, adjusted EBITDA was (1.4)% compared to 10.5% in the first quarter of 2023.

Ascent Tubular - net sales from continuing operations in the first quarter of 2024 were $23.8 million compared to $31.1 million in the first quarter of 2023. Operating loss from continuing operations in the first quarter decreased to $1.5 million compared to operating loss from continuing operations of $3.3 million in the prior year period. Adjusted EBITDA from continuing operations in the first quarter was $(0.7) million compared to $(2.4) million in the prior year period. As a percentage of segment net sales, adjusted EBITDA was (3.0)% compared to (7.7)% in the first quarter of 2023.

Liquidity

As of March 31, 2024, the Company had no debt outstanding under its revolving credit facilities and had $63.6 million in availability under its revolving credit facility.

For the quarter ended March 31, 2024, the Company repurchased 16,330 shares at an average cost of $9.97 per share for approximately $0.2 million.

Conference Call

Ascent will conduct a conference call today at 5:00 p.m. Eastern time to discuss its results for the first quarter ended March 31, 2024.

Ascent management will host the conference call, followed by a question-and-answer period.

Date: Wednesday, May 8, 2024 Time: 5:00 p.m. Eastern time Live Call Registration Link: Here Webcast Registration Link: Here

To access the call by phone, please register via the live call registration link above or here and you will be provided with dial-in instructions and details. If you have any difficulty connecting with the conference call, please contact Gateway Group at 1-949-574-3860.

The conference call will also be broadcast live and available for replay via the webcast registration link above or here. The webcast will be archived for one year in the investor relations section of the Company's website at www.ascentco.com.

About Ascent Industries Co.

Ascent Industries Co. (Nasdaq: ACNT) is a company that engages in a number of diverse business activities including the production of specialty chemicals and industrial tubular products. For more information about Ascent, please visit its website at www.ascentco.com.

Forward-Looking Statements

This press release may include "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and other applicable federal securities laws. All statements that are not historical facts are forward-looking statements. Forward-looking statements can be identified through the use of words such as "estimate," "project," "intend," "expect," "believe," "should," "anticipate," "hope," "optimistic," "plan," "outlook," "should," "could," "may" and similar expressions. The forward-looking statements are subject to certain risks and uncertainties which could cause actual results to differ materially from historical results or those anticipated. Readers are cautioned not to place undue reliance on these forward-looking statements and to review the risks as set forth in more detail in Ascent Industries Co.'s Securities and Exchange Commission filings, including our Annual Report on Form 10-K, which filings are available from the SEC or on our website. Ascent Industries Co. assumes no obligation to update any forward-looking information included in this release.

Non-GAAP Financial Information

Financial statement information included in this earnings release includes non-GAAP (Generally Accepted Accounting Principles) measures and should be read along with the accompanying tables which provide a reconciliation of non-GAAP measures to GAAP measures.

Adjusted EBITDA is a non-GAAP financial measure that the Company believes is useful to investors in evaluating its results to determine the value of a company. An item is excluded in the measure if its periodic value is inconsistent and sufficiently material that not identifying the item would render period comparability less meaningful to the reader or if including the item provides a clearer representation of normalized periodic earnings. The Company excludes in Adjusted EBITDA two categories of items: 1) Base EBITDA components, including: interest expense, income taxes, depreciation and amortization, and 2) Material transaction costs including: goodwill impairment, asset impairment, gain on lease modification, stock-based compensation, non-cash lease cost, acquisition costs and other fees, shelf registration costs, loss on extinguishment of debt, retention costs and restructuring & severance costs from net income.

Management believes that these non-GAAP measures are useful because they are key measures used by our management team to evaluate our operating performance, generate future operating plans and make strategic decisions as well as allow readers to compare the financial results between periods. Non-GAAP measures should not be considered as an alternative to any measure of performance or financial condition as promulgated under GAAP, and investors should consider the Company's performance and financial condition as reported under GAAP and all other relevant information when assessing the performance or financial condition of the Company. Non-GAAP measures have limitations as analytical tools, and investors should not consider them in isolation or as a substitute for analysis of the Company's results or financial condition as reported under GAAP.

Ascent Industries Co.
Condensed Consolidated Balance Sheets
(in thousands, except par value and share data)
                                                                                                                                                                         
                                                                                                                                                    (Unaudited)                                                  
                                                                                                                                                  March 31, 2024                                                  December 31, 2023
                                                                                                                                             ------------------------------------------------------------                        ------------------------------------------------------------
Assets                                                                                                                                                                                      
Current assets:                                                                                                                                                                             
                                                                                                                                                                $                1,299                        $                1,851  
   Cash and cash equivalents
                                                                                                                                                             28,160                     26,604  
   Accounts receivable, net of allowance for credit losses of $792 and $463, respectively
                                                                                                                                                             51,197                     52,306  
   Inventories
                                                                                                                                                              4,146                      4,879  
   Prepaid expenses and other current assets
                                                                                                                                                              1,792                      2,912  
   Assets held for sale
                                                                                                                                                                 46                        861  
   Current assets of discontinued operations
                                                                                                                                             -------------------- -------------------- --------------------                      -------------------- -------------------- --------------------
                                                                                                                                                             86,640                     89,413  
      Total current assets
                                                                                                                                                             28,648                     29,755  
   Property, plant and equipment, net
                                                                                                                                                             27,431                     27,784  
   Right-of-use assets, operating leases, net
                                                                                                                                                              8,129                      8,496  
   Intangible assets, net
                                                                                                                                                              7,366                      5,808  
   Deferred income taxes
                                                                                                                                                                 79                        104  
   Deferred charges, net
                                                                                                                                                              2,678                      1,935  
   Other non-current assets, net
                                                                                                                                             -------------------- -------------------- --------------------                      -------------------- -------------------- --------------------
Total assets                                                                                                                                                    $              160,971                        $              163,295  
                                                                                                                                             ==================== ==================== ====================                      ==================== ==================== ====================
                                                                                                                                                                         
Liabilities and Shareholders' Equity                                                                                                                                                        
Current liabilities:                                                                                                                                                                        
                                                                                                                                                                $               20,549                        $               16,416  
   Accounts payable
                                                                                                                                                              4,824                      5,108  
   Accrued expenses and other current liabilities
                                                                                                                                                                 88                        360  
   Current portion of note payable
                                                                                                                                                              1,170                      1,140  
   Current portion of operating lease liabilities
                                                                                                                                                                288                        292  
   Current portion of finance lease liabilities
                                                                                                                                                              1,376                      1,473  
   Current liabilities of discontinued operations
                                                                                                                                             -------------------- -------------------- --------------------                      -------------------- -------------------- --------------------
                                                                                                                                                             28,295                     24,789  
      Total current liabilities
                                                                                                                                                             29,419                     29,729  
   Long-term portion of operating lease liabilities
                                                                                                                                                              1,236                      1,307  
   Long-term portion of finance lease liabilities
                                                                                                                                                                 57                         60  
   Other long-term liabilities
                                                                                                                                             -------------------- -------------------- --------------------                      -------------------- -------------------- --------------------
                                                                                                                                                             30,712                     31,096  
      Total non-current liabilities
                                                                                                                                             -------------------- -------------------- --------------------                      -------------------- -------------------- --------------------
Total liabilities                                                                                                                                               $               59,007                        $               55,885  
                                                                                                                                             -------------------- -------------------- --------------------                      -------------------- -------------------- --------------------
                                                                                                                                                                         
Commitments and contingencies                                                                                                                                                               
                                                                                                                                                                         
Shareholders' equity:                                                                                                                                                                       
                                                                                                                                                                $               11,085                        $               11,085  
   Common stock, par value $1 per share; 24,000,000 shares authorized; 11,085,103 and 10,124,781 shares issued and outstanding, respectively
                                                                                                                                                             47,097                     47,333  
   Capital in excess of par value
                                                                                                                                                             53,024                     58,517  
   Retained earnings
                                                                                                                                             -------------------- -------------------- --------------------                      -------------------- -------------------- --------------------
                                                                                                                                                            111,206                    116,935  
    
                                                                                                                                                             (9,242                    )                   (9,525                    )
   Less: cost of common stock in treasury - 960,323 and 990,282 shares, respectively
                                                                                                                                             -------------------- -------------------- --------------------                      -------------------- -------------------- --------------------
                                                                                                                                                            101,964                    107,410  
      Total shareholders' equity
                                                                                                                                             -------------------- -------------------- --------------------                      -------------------- -------------------- --------------------
Total liabilities and shareholders' equity                                                                                                                      $              160,971                        $              163,295  
                                                                                                                                             ==================== ==================== ====================                      ==================== ==================== ====================
                                                                                                                                       
Note: The condensed consolidated balance sheets at December 31, 2023 have been derived from the audited consolidated financial statements at that date.
                                              
Ascent Industries Co.
Condensed Consolidated Statements of Income (Loss) - Comparative Analysis (Unaudited)
($ in thousands, except per share data)
                                              
                                                                                                     Three Months Ended
                                                                                                                             March 31,
                                                                ----------------------------------------------------------------------------------------------------------------------------
                                                                       2024                                                     2023
                                                                ------------------------------------------------------                        --------------------------------------------------
Net sales                                                                                                
                                                                                   $         23,814                        $     31,061  
   Tubular Products
                                                                          20,296           23,749  
   Specialty Chemicals
                                                                  --               50  
   All Other
                                                                -------------------- -------------- --------------------                      -------------------- ---------- --------------------
                                                       44,110           54,860  
                                                                ==================== ============== ====================                      ==================== ========== ====================
Operating (loss) income from continuing operations                                                                          
                                                                          (1,502                    )         (3,293                    )
   Tubular Products
                                                                          (1,439                    )          1,352  
   Specialty Chemicals
                                                                            (162                    )           (479                    )
   All Other
                                                                                      
Corporate                                                                                                
                                                                          (2,150                    )         (3,704                    )
      Unallocated corporate expenses
                                                                  --             (259                    )
      Acquisition costs and other
                                                                -------------------- -------------- --------------------                      -------------------- ---------- --------------------
                                                                          (2,150                    )         (3,963                    )
   Total Corporate
                                                                -------------------- -------------- --------------------                      -------------------- ---------- --------------------
                                                                          (5,253                    )         (6,383                    )
   Operating loss
                                                                             127            1,107  
      Interest expense
                                                                            (120                    )            (95                    )
      Other, net
                                                                -------------------- -------------- --------------------                      -------------------- ---------- --------------------
Loss from continuing operations before income taxes                       (5,260                    )         (7,395                    )
                                                                          (1,166                    )         (1,607                    )
   Income tax benefit
                                                                -------------------- -------------- --------------------                      -------------------- ---------- --------------------
                                                                          (4,094                    )         (5,788                    )
   Loss from continuing operations
                                                                          (1,399                    )            589  
   (Loss) income from discontinued operations, net of tax
                                                                -------------------- -------------- --------------------                      -------------------- ---------- --------------------
Net loss                                                                           $         (5,493                    )                      $     (5,199                    )
                                                                ==================== ============== ====================                      ==================== ========== ====================
                                                                                      
Net loss per common share from continuing operations                                                     
                                                                                   $          (0.41                    )                      $      (0.57                    )
   Basic
                                                                                   $          (0.41                    )                      $      (0.57                    )
   Diluted
                                                                                      
Net (loss) income per common share from discontinued operations                                          
                                                                                   $          (0.14                    )                      $       0.06  
   Basic
                                                                                   $          (0.14                    )                      $       0.06  
   Diluted
                                                                                      
Net loss per common share                                                                                
                                                                                   $          (0.54                    )                      $      (0.51                    )
   Basic
                                                                                   $          (0.54                    )                      $      (0.51                    )
   Diluted
                                                                                      
Average shares outstanding                                                                               
                                                                          10,094           10,148  
   Basic
                                                                          10,094           10,148  
   Diluted
                                                                                      
Other data:                                                                                              
(1)The term Adjusted EBITDA is a non-GAAP financial measure that the Company believes is useful to investors in evaluating its results to determine the value of a company. An item is excluded in the measure if its periodic value is inconsistent and sufficiently material that not identifying the item would render period comparability less meaningful to the reader or if including the item provides a clearer representation of normalized periodic earnings. The Company excludes in Adjusted EBITDA two categories of items: 1) Base EBITDA components, including: interest expense, income taxes, depreciation and amortization, and 2) Material transaction costs including: goodwill impairment, asset impairment, gain on lease modification, stock-based compensation, non-cash lease cost, acquisition costs and other fees, retention costs and restructuring & severance costs from net income. For a reconciliation of this non-GAAP measure to the most comparable GAAP equivalent, refer to the Reconciliation of Net Income (Loss) to Adjusted EBITDA.
 
Ascent Industries Co.
Consolidated Statements of Cash Flows (Unaudited)
($ in thousands)
                                                              
                                                                                                               Three Months Ended March 31,
                                                                                -------------------------------------------------------------------------------------------------------------------------
                                                                                       2024                                                    2023
                                                                                ------------------------------------------------------                        -----------------------------------------------
Operating activities                                                                                                     
Net loss                                                                                           $         (5,493                    )                      $  (5,199                    )
(Loss) income from discontinued operations, net of tax                                    (1,399                    )         589  
                                                                                -------------------- -------------- --------------------                      -------------------- ------- --------------------
Net loss from continuing operations                                                       (4,094                    )      (5,788                    )
Adjustments to reconcile net loss to net cash provided by operating activities:                                                                       
                                                                                           1,522         1,549  
   Depreciation expense
                                                                                             367           376  
   Amortization expense
                                                                                              25            25  
   Amortization of debt issuance costs
                                                                                          (1,166                    )         353  
   Deferred income taxes
                                                                                             330           (57                    )
   Provision for (reduction of) losses on accounts receivable
                                                                                             (73                    )         791  
   (Reduction of) provision for losses on inventories
                                                                                  --           182  
   Loss on disposal of property, plant and equipment
                                                                                              55            64  
   Non-cash lease expense
                                                                                             209           319  
   Stock-based compensation expense
                                                                                                                                                      
   Changes in operating assets and liabilities:
                                                                                          (1,885                    )      (1,072                    )
        Accounts receivable
                                                                                           1,182         9,492  
        Inventories
                                                                                             (73                    )         297  
        Other assets and liabilities
                                                                                           4,022         6,827  
        Accounts payable
                                                                                            (283                    )       1,629  
        Accrued expenses
                                                                                              78        (2,577                    )
        Accrued income taxes
                                                                                -------------------- -------------- --------------------                      -------------------- ------- --------------------
Net cash provided by operating activities - continuing operations                            216        12,410  
Net cash provided by operating activities - discontinued operations                           47           980  
                                                                                -------------------- -------------- --------------------                      -------------------- ------- --------------------
Net cash provided by operating activities                                                    263        13,390  
                                                                                -------------------- -------------- --------------------                      -------------------- ------- --------------------
Investing activities                                                                                                                                  
                                                                                            (305                    )        (586                    )
   Purchases of property, plant and equipment
                                                                                -------------------- -------------- --------------------                      -------------------- ------- --------------------
Net cash used in investing activities - continuing operations                               (305                    )        (586                    )
Net cash used in investing activities - discontinued operations                   --          (238                    )
                                                                                -------------------- -------------- --------------------                      -------------------- ------- --------------------
Net cash used in investing activities                                                       (305                    )        (824                    )
                                                                                -------------------- -------------- --------------------                      -------------------- ------- --------------------
Financing activities                                                                                                                                  
                                                                                          50,950        67,488  
   Borrowings from long-term debt
                                                                                         (50,950                    )     (80,384                    )
   Payments on long-term debt
                                                                                            (271                    )        (289                    )
   Payments on note payable
                                                                                             (76                    )         (74                    )
   Principal payments on finance lease obligations
                                                                                            (163                    )        (327                    )
   Repurchase of common stock
                                                                                -------------------- -------------- --------------------                      -------------------- ------- --------------------
Net cash used in financing activities                                                       (510                    )     (13,586                    )
                                                                                -------------------- -------------- --------------------                      -------------------- ------- --------------------
                                                                                            (552                    )      (1,020                    )
   Decrease in cash and cash equivalents
                                                                                  --             1  
   Less: Cash and cash equivalents of discontinued operations
Cash and cash equivalents, beginning of period                                             1,851         1,440  
                                                                                -------------------- -------------- --------------------                      -------------------- ------- --------------------
Cash and cash equivalents, end of period                                                           $          1,299                        $     421  
                                                                                ==================== ============== ====================                      ==================== ======= ====================
                                                           
Ascent Industries Co.
Non-GAAP Financial Measures Reconciliation
Reconciliation of Net Income (Loss) to Adjusted EBITDA (Unaudited)
($ in thousands)
                                                                            Three Months Ended
                                                                                                    March 31,
                                     --------------------------------------------------------------------------------------------------------------------------------
($ in thousands)                                               2024                                                       2023
                                     ------------------------------------------------------                        ------------------------------------------------------
Consolidated                                                                  
Net loss from continuing operations                     $         (4,094                    )                      $         (5,788                    )
Adjustments:                                                                  
                                                  127                1,106  
   Interest expense
                                               (1,166                    )             (1,607                    )
   Income taxes
                                                1,522                1,549  
   Depreciation
                                                  367                  376  
   Amortization
                                     -------------------- -------------- --------------------                      -------------------- -------------- --------------------
EBITDA                                         (3,244                    )             (4,364                    )
                                                   12                  261  
   Acquisition costs and other
                                                   59                  220  
   Stock-based compensation
                                                   55                   64  
   Non-cash lease expense
                                                    3       --  
   Retention expense
                                       --                   84  
   Restructuring and severance costs
                                     -------------------- -------------- --------------------                      -------------------- -------------- --------------------
Adjusted EBITDA                                         $         (3,115                    )                      $         (3,735                    )
                                     ==================== ============== ====================                      ==================== ============== ====================
                                                           
Specialty Chemicals                                                           
Net (loss) income                                       $         (1,458                    )                      $          1,342  
Adjustments:                                                                  
                                                   19                   12  
   Interest expense
                                                  954                  952  
   Depreciation expense
                                                  169                  158  
   Amortization expense
                                     -------------------- -------------- --------------------                      -------------------- -------------- --------------------
EBITDA                                           (316                    )              2,464  
                                       --                    2  
   Acquisition costs and other
                                                    7                    8  
   Stock-based compensation
                                                   19                   24  
   Non-cash lease expense
                                     -------------------- -------------- --------------------                      -------------------- -------------- --------------------
Specialty Chemicals Adjusted EBITDA                     $           (290                    )                      $          2,498  
                                     ==================== ============== ====================                      ==================== ============== ====================
                                                 (1.4                   )%               10.5                    %
   % segment sales
                                                           
Tubular Products                                                                                                  
Net loss from continuing operations                     $         (1,502                    )                      $         (3,293                    )
Adjustments:                                                                                                      
                                                  544                  575  
   Depreciation expense
                                                  198                  218  
   Amortization expense
                                     -------------------- -------------- --------------------                      -------------------- -------------- --------------------
EBITDA                                           (760                    )             (2,500                    )
                                                   12       --  
   Acquisition costs and other
                                                   11                  (20                    )
   Stock-based compensation
                                                   25                   31  
   Non-cash lease expense
                                       --                   84  
   Restructuring and severance costs
                                     -------------------- -------------- --------------------                      -------------------- -------------- --------------------
Tubular Products Adjusted EBITDA                        $           (712                    )                      $         (2,405                    )
                                     ==================== ============== ====================                      ==================== ============== ====================

View source version on businesswire.com: https://www.businesswire.com/news/home/20240508735760/en/

SOURCE: Ascent Industries Co.

<img alt="" src="https://cts.businesswire.com/ct/CT?id=bwnews&sty=20240508735760r1&sid=cmtx6&distro=nx&lang=en" style="width:0;height:0" />

Company Contact 
Ryan Kavalauskas
Chief Financial Officer
1-630-884-9181


Investor Relations 
Cody Slach and Cody Cree
Gateway Group, Inc.
1-949-574-3860
ACNT@gateway-grp.com
comtex tracking

COMTEX_452079760/1006/2024-05-08T16:05:19

Do not sell my personal information

Copyright © 2024. All market data is provided by Barchart Solutions. Information is provided "as is" and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer.